Vitura Health milestone announcement

Vitura Health Limited (ASX: $VIT) has announced the sale of the 2 millionth unit of medicinal cannabis through its CanView platform. Launched in June 2020, the platform has achieved a yearly run rate of approximately 1,000,000 units, stocking 280+ product lines from over 39 leading domestic and international brands in Australia.

Executive commentary on milestone achievement

With today's announcement of our 2 millionth unit of a medicinal cannabis product through our market leading CanView platform, Vitura Health is very proud to recognize such a significant milestone in the Company's history. With the continued growth of unit sales, we anticipate that the 3.0 millionth unit should be sold through the platform during the 2024 calendar year. The deployment of the CanView 2.0 software has offered patients, prescribers, pharmacists and suppliers increased functionality, ease of use and efficiencies that is expected to drive further adoption and usage. These significant achievements could not have been realized without the efforts of the amazing Vitura Health team. This success demonstrates the clear positive network effects on the platform and the scalability of the CanView business model which we believe will continue to deliver growth and further shareholder value. Importantly, with Vitura Health's focus on the care of our patients and access to medicinal cannabis, we look forward to continuing to serve our patients, prescribers, pharmacists and suppliers.

Summary of Vitura Health's milestone and outlook

Vitura Health Limited (ASX: $VIT) has achieved a significant milestone with the sale of the 2 millionth unit of medicinal cannabis through its CanView platform. The rapid acceleration in sales from 2.5 years to sell the first 1 million units to only 1 year to sell the second 1 million units demonstrates the platform's growing adoption and usage. The deployment of the CanView 2.0 software is expected to drive further adoption and usage, offering increased functionality, ease of use, and efficiencies for patients, prescribers, pharmacists, and suppliers. Vitura Health anticipates the sale of the 3.0 millionth unit through the platform in the 2024 calendar year. The company's focus on patient care and access to medicinal cannabis positions it for continued growth and further shareholder value.